ArticleMedical oncology (Northwood, London, England)2021

Short-term outcomes of risk-adapted upfront docetaxel administration in patients with metastatic hormone-sensitive prostate cancer: a multicenter prospective study in Japan.

Yumina Muto et al.PubMed ↗Publisher ↗

No numbers read from the abstract.